...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

 "If the end game for Zenith is a buyout and they come to an agreement to sell, the OTC shares are entitiled to no payout."

I don't believe that to be the case.

 

IMO ... Koo

 

Share
New Message
Please login to post a reply